Last updated: May 29, 2026

Application No. 17/995,700

TREATMENT FOR SEPSIS-INDUCED ORGAN DYSFUNCTION

Non-Final OA

Filed

Oct 06, 2022

Priority

Apr 08, 2020 — AU 2020901120 +1 more

Examiner

VALLE, ERNESTO

Art Unit

1623

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Rinaldo Bellomo

OA Round

1 (Non-Final)

This examiner grants 60% of cases after interview

— +33.3% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 20 resolved cases, 2023–2026

Examiner Intelligence

VALLE, ERNESTO View full profile →

Grants 60% of resolved cases

Career Allowance Rate

12 granted / 20 resolved

At TC average

Strong +33% interview lift

Without

With

+33.3%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

38 currently pending

Career history

Total Applications

across all art units

Statute-Specific Performance

§103

62.7%

+22.7% vs TC avg

§102

12.7%

-27.3% vs TC avg

§112

9.1%

-30.9% vs TC avg

Black line = Tech Center average estimate • Based on career data from 20 resolved cases

Prosecution Timeline

Oct 06, 2022

Application Filed

Sep 10, 2025

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

17/757,944

Patent 12589092

POLYCYCLIC COMPOUND ACTING AS KINASE INHIBITOR

3y 9m to grant Granted Mar 31, 2026

17/659,121

Patent 12582628

METHODS FOR TREATING BREAST CANCER

3y 11m to grant Granted Mar 24, 2026

17/681,197

Patent 12564569

CARBOPLATIN COMPLEX AND PHARMACEUTICAL PREPARATION THEREOF

4y 0m to grant Granted Mar 03, 2026

19/073,111

Patent 12558428

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

11m to grant Granted Feb 24, 2026

17/787,000

Patent 12552746

PROCESS AND INTERMEDIATES FOR THE PREPARATION OF UPADACITINIB

3y 8m to grant Granted Feb 17, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

60%

Grant Probability

93%

With Interview (+33.3%)

3y 3m (~0m remaining)

Median Time to Grant

Low

PTA Risk

Based on 20 resolved cases by this examiner. Grant probability derived from career allowance rate.